Edward Brennan
Präsident bei InClinica, Inc.
Vermögen: 223 375 $ am 31.03.2024
Profil
Edward J.
Brennan is currently the Director at Skinject, Inc., the President & Chief Medical Officer at InClinica, Inc., and the Chief Medical Officer at Medicus Pharma Ltd.
Previously, he served as an Independent Director at Solarvest BioEnergy, Inc. in 2020.
He also held positions as a Medical Director at Wyeth-Ayerst Research and GlaxoSmithKline LLC.
Additionally, he served as the President-BioSciences Division at FSD Pharma, Inc. Dr. Brennan obtained a doctorate degree from Temple University School of Medicine and an undergraduate degree from Philadelphia College of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,77% | 24.10.2023 | 125 000 ( 0,77% ) | 223 375 $ | 31.03.2024 |
Aktive Positionen von Edward Brennan
| Unternehmen | Position | Beginn |
|---|---|---|
InClinica, Inc.
 InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Präsident | - |
Skinject, Inc.
 Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Direktor/Vorstandsmitglied | 18.10.2023 |
Ehemalige bekannte Positionen von Edward Brennan
| Unternehmen | Position | Ende |
|---|---|---|
| SOLARVEST BIOENERGY INC. | Direktor/Vorstandsmitglied | 25.11.2020 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Wyeth-Ayerst Research | Technik-/Wissenschafts-/F&E-Leiter | - |
| FSD PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Edward Brennan
| Temple University School of Medicine | Doctorate Degree |
| Philadelphia College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLARVEST BIOENERGY INC. | Utilities |
| FSD PHARMA INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
InClinica, Inc.
InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Health Technology |
| Wyeth-Ayerst Research | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Skinject, Inc.
Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Health Services |
